These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7992237)

  • 1. The low pH stability of human coagulation factor XII (Hageman factor) is due to reversible conformational transitions.
    Samuel M; Samuel E; Villanueva GB
    Thromb Res; 1994 Aug; 75(3):259-68. PubMed ID: 7992237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.
    Samuel M; Pixley RA; Villanueva MA; Colman RW; Villanueva GB
    J Biol Chem; 1992 Sep; 267(27):19691-7. PubMed ID: 1527088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surface-dependent autoactivation mechanism of factor XII.
    Røjkjaer R; Schousboe I
    Eur J Biochem; 1997 Jan; 243(1-2):160-6. PubMed ID: 9030735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model demonstrating different interactions of human coagulation factor XII (Hageman factor) with the surface at physiological and lower pH.
    Samuel E; Samuel M; Villanueva GB
    Biochem Mol Biol Int; 1994 Aug; 33(5):827-34. PubMed ID: 7987251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.
    McMillin CR; Saito H; Ratnoff OD; Walton AG
    J Clin Invest; 1974 Dec; 54(6):1312-22. PubMed ID: 4373492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.
    Silverberg M; Diehl SV
    Biochem J; 1987 Dec; 248(3):715-20. PubMed ID: 2449171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Zn2+ on the kinetic events that contribute to the 500-kDa dextran-sulfate-dependent activation of factor XII (Hageman factor).
    Loiseau C; Randriamahazaka HN; Nigretto JM
    Eur J Biochem; 1997 May; 246(1):204-10. PubMed ID: 9210485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
    Maas C; Govers-Riemslag JW; Bouma B; Schiks B; Hazenberg BP; Lokhorst HM; Hammarström P; ten Cate H; de Groot PG; Bouma BN; Gebbink MF
    J Clin Invest; 2008 Sep; 118(9):3208-18. PubMed ID: 18725990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explicit constants for the dextran-sulfate-mediated activation and autoactivation of purified human factor XII (Hageman factor).
    Loiseau C; Randriamahazaka HN; Nigretto JM
    Eur J Biochem; 1996 Aug; 239(3):692-701. PubMed ID: 8774715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of activation and autoactivation of human factor XII.
    Tankersley DL; Finlayson JS
    Biochemistry; 1984 Jan; 23(2):273-9. PubMed ID: 6607744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of ionic interactions to the conformational stability and function of polygalacturonase from A. niger.
    Jyothi TC; Singh SA; Appu Rao AG
    Int J Biol Macromol; 2005 Sep; 36(5):310-7. PubMed ID: 16122785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ordered adsorption of coagulation factor XII on negatively charged polymer surfaces probed by sum frequency generation vibrational spectroscopy.
    Chen X; Wang J; Paszti Z; Wang F; Schrauben JN; Tarabara VV; Schmaier AH; Chen Z
    Anal Bioanal Chem; 2007 May; 388(1):65-72. PubMed ID: 17205260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.